KRAS D153V [plasma membrane]

Stable Identifier
R-HSA-6802292
Type
Protein [EntityWithAccessionedSequence]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
Literature References
PubMed ID Title Journal Year
20949621 Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders

Cirstea, IC, Ahmadian, MR, Merbitz-Zahradnik, T, Zenker, M, Dvorsky, R, Gremer, L, Wittinghofer, A, Kratz, CP

Hum. Mutat. 2011
Participates
Other forms of this molecule
Modified Residues
Name
L-aspartic acid 153 replaced with L-valine
Coordinate
153
PsiMod
A protein modification that effectively converts a source amino acid residue to an L-valine.
A protein modification that effectively removes or replaces an L-aspartic acid.
Disease
Name Identifier Synonyms
Noonan syndrome DOID:3490 Turner's phenotype, karyotype normal (disorder)
Cross References
Guide to Pharmacology - Targets
ClinGen
OpenTargets
ZINC - Substances
ZINC target
PRO
PDB
6VC8, 6O4Y, 8FMK, 5MLB, 8I5E, 4Q02, 5US4, 8TXE, 4NMM, 8V39, 6OB2, 4LDJ, 6CU6, 1KZO, 8BLR, 6WS4, 7W5R, 6BP1, 6O36, 6ZLI, 6V5L, 8AQ5, 6PTW, 6CC9, 8TBJ, 4M1S, 9BHP, 7SCW, 4WA7, 6GQW, 5XCO, 5YY1, 3GFT, 7LGI, 7U8H, 8G9P, 8B69, 8DNI, 4EPT, 8G47, 7R0M, 5UFE, 4Q01, 5MLA, 5WHD, 8I5D, 6O51, 6MQG, 8F0M, 6EPL, 8ONV, 8T74, 6EPO, 5WLB, 6FA3, 5UK9, 8DGS, 7A47, 7LC2, 8JHL, 7RP2, 7ACH, 5V6V, 8STN, 4PZZ, 6GJ7, 8AFB, 5W22, 5VPY, 4LPK, 7RT1, 7C41, 6CCH, 6GQT, 6GOE, 8T4V, 1D8D, 4EPY, 8CPR, 6ZL5, 6M9W, 2MSE, 8I5C, 8CX5, 6XHB, 8BE4, 7NY8, 8UN4, 7TLK, 8TXG, 6W4E, 8G42, 8AZX, 8T73, 6E6F, 4LYJ, 8TXH, 4DSO, 6FA4, 8V3A, 6USZ, 4PZY, 6T5U, 8AQ7, 4Q03, 9BFY, 8STM, 5VQ2, 7A1Y, 5O2S, 8TBN, 1N4P, 6V65, 8VGQ, 5VPI, 6P8Z, 6B0V, 6QUW, 8TBM, 8G4H, 4EPR, 4EPX, 5OCG, 6JTN, 8VRA, 7F0W, 6MS9, 7EW9, 6WS2, 8UN3, 8EIE, 8BE3, 6O4Z, 8FMJ, 5TB5, 8VRB, 8T75, 8QU8, 9AX6, 8YIV, 6EPP, 8JJS, 8TY2, 6H46, 5VBM, 4LYH, 7ACQ, 6T5V, 8UN5, 7KMR, 5V9O, 6GJ8, 5VPZ, 6QUU, 8JGD, 7RT4, 9BHO, 8TBL, 7C40, 6E6G, 5VQ0, 7A1W, 6JTP, 8EER, 6P8X, 6XGU, 7RPZ, 8DNK, 8VJZ, 4M1W, 6ASA, 6JTO, 8FMI, 6XHA, 5WHE, 6O46, 4DSN, 8AZR, 8YJ2, 8RRO, 6W4F, 6FA1, 4L8G, 8EZG, 8TXK, 8ECR, 7KYZ, 4OBE, 8R7X, 7ACF, 6H47, 5V9L, 6GJ5, 6TAM, 6PTS, 8TBF, 6GOF, 5OCO, 5YXZ, 8AFD, 9BI2, 4M22, 7VVB, 6GQX, 5VQ1, 7RSC, 1N4Q, 6MBU, 7A1X, 7RT5, 8PIY, 4EPW, 6UT0, 8DNJ, 6XGV, 6ARK, 6N2J, 5V71, 8EBZ, 7R0Q, 8TY8, 6EPM, 8AZZ, 7YCC, 5WHB, 6CCX, 4LUC, 4LYF, 6O53, 5USJ, 5WPM, 8R7W, 5F2E, 6OIM, 8TVK, 6USX, 6TAN, 6OB3, 8T72, 8PI0, 5VQ8, 8QW7, 7Q9U, 4M1Y, 5VP7, 9BHQ, 4TQA, 6GQY, 8TBH, 7RT3, 8QUG, 1N4R, 7RSE, 5VQ6, 7OK4, 6P8Y, 5KYK, 5O2T, 2MSC, 6VJJ, 6PQ3, 5TAR, 7TLG, 8WUL, 6MQN, 8BE5, 7YUZ, 7LC1, 8B6I, 7EWB, 6MNX, 8AZY, 8T71, 7YV1, 5UQW, 8EPW, 8DGT, 6BOF, 8TXJ, 7MQU, 4QL3, 7RP4, 6GJ6, 7KFZ, 7LZ5, 6MTA, 5UFQ, 8B78, 9BG1, 6GOG, 8EDY, 4M21, 8QW6, 8G4F, 7T1F, 6P8W, 6MBQ, 8B00, 5OCT, 1N4S, 8G9Q, 7T47, 6QUX, 4M1T, 6YR8, 6PGO, 7EYX, 8TBK, 7ROV, 6B0Y, 7O70, 5WHA, 6YXW, 6ASE, 6N2K, 7EWA, 6EPN, 6FA2, 7STF, 6T5B, 5V6S, 7MDP, 6V6F, 8TY9, 7YCE, 7ACA, 7OO7, 6WGN, 1KZP, 8AZV, 7TLE, 6F76, 7RP3, 5V9U, 8UDR, 4LRW, 8AFC, 6MBT, 4TQ9, 8QVU, 1D8E, 7SCX, 8VR9, 8DVG, 7RT2, 9BI1, 8S8C, 6PGP, 6P0Z, 6GOD, 7OK3, 6QUV, 6GOM, 4M1O, 7R0N, 2MSD, 8WTE, 4EPV, 8X6R, 4LV6
GeneCards
Pharos - Targets
Orphanet
HMDB Protein
Interactors (13)
Accession #Entities Entities Confidence Score Evidence (IntAct)
 UniProt:P04049 RAF1  20 0.695 6
 UniProt:P15056 BRAF  20 0.68 5
 UniProt:Q99755 PIP5K1A  1 0.661 9
 UniProt:Q96II5 Q96II5      0.556 3
 UniProt:P50749 RASF2      0.544 2
 UniProt:P61586 RHOA  6 0.519 2
 UniProt:O75915 ARL6IP5  1 0.519 2
 UniProt:P10398 ARAF  4 0.483 2
 UniProt:Q9UQB8 BAIAP2  1 0.483 2
 UniProt:P28288 ABCD3  2 0.483 2
 UniProt:P01111 NRAS  20 0.483 2
 UniProt:Q7KZI7 MARK2      0.483 2
 ChEBI:16618 1-PHOSPHATIDYL-1D-MYO-INOSITOL 3,4,5-TRISPHOSPHATE      0.462 2
Cite Us!